Form 4: SenesTech Director Matthew K. Szot Acquires Stock Options
SEC Form 4 Filing
Director Matthew K. Szot acquired stock options in SenesTech, Inc. on August 27, 2024.
Summary
- On August 27, 2024, Matthew K. Szot, a director of SenesTech, Inc., acquired 12,090 stock options with an exercise price of $2.81.
- These options vest in four equal installments, starting November 27, 2024, and completing on August 27, 2025, or at the first annual meeting of stockholders after the grant date, whichever is earlier, contingent upon continued service to the corporation.
- Following the transaction, Szot directly owns 12,090 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants, which is neither inherently positive nor negative.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule implies continued service and potential future equity ownership by the director.
Industry Context
This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency regarding the equity ownership of company directors.
Comparison to Industry Standards
- Stock option grants to directors are a common practice in publicly traded companies as part of their compensation packages.
- The vesting schedule described is fairly standard, aligning the director's interests with the long-term performance of the company.
- Comparable companies in the biotechnology or pest control industries also utilize stock options as a form of executive compensation.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's increased alignment with the company's success.
Key Dates
| Date | Description |
|---|---|
| 08/27/2024 | Date of transaction: Matthew K. Szot acquired stock options. |
| 08/27/2024 | Date of report. |
| 11/27/2024 | First vesting date for 25% of the stock options. |
| 02/27/2025 | Second vesting date for 25% of the stock options. |
| 05/27/2025 | Third vesting date for 25% of the stock options. |
| 08/27/2025 | Final vesting date for 25% of the stock options, or the first annual meeting of stockholders after the grant date, whichever is earlier. |
| 08/27/2034 | Expiration date of the stock options. |
Keywords
SenesTech, Director, Stock Options, Acquisition, Form 4, SNES, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.